
|Articles|March 11, 2022
Choose Eurofins’ new state-of-the-art aseptic sterile fill/finish for clinical supplies
Author(s)Eurofins BioPharma Product Testing
Industry changes, such as shorter timelines and increased product complexity, can often introduce additional risks to the sterile fill/finish process, resulting in production delays, additional costs, and safety concerns.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
The Year of AI: 2025’s Bio/pharma Upskilling Revolution
2
How GLP-1s, Digital Tech, and 505(b)(2) Strategies Are Reshaping the CDMO Landscape
3
Onshoring Requires a Plan for Training
4
Strategies for Building Pharmaceutical Supply Chain Resilience in a Shifting Market
5